Mansoura university hospital
Al Mansurah, Dakahlia Governorate, Egypt
NCT Number: NCT02645240
The study aims to identify several factors that can accurately predict the incident of intestinal infraction in patients with mesenteric vascular occlusion or ischemia.
Looking for future studies?
Notify Me16 year–85 year
All sexes
Interventional
Phase 4
Al Mansurah, Dakahlia Governorate, Egypt
The study aims to identify several clinical, laboratory, and radiologic factors that can accurately predict the occurrence of intestinal infraction in patients with mesenteric vascular occlusion or ischemia in order to prevent unnecessary surgical intervention in patients with just intestinal ischemia and to hasten intervention in patients with actual intestinal gangrene.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Intravenous heparin injection in patients with acute mesenteric ischemia and evaluating their response within 24 hours
Other names: Low molecular weight heparin injection
Time frame: 48 hours
Number of patients with resolved abdominal symptoms and incidence of patients developing shock
Mansoura University
Other
Predictive Factors of Intestinal Infraction in Patients With Acute Mesenteric Ischemia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03941015
Acute Kidney Injury, Brain Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT04671979
Cardiovascular Diseases, Digestive System Diseases
Bogotá, Cundinamarca, Colombia
View Trial DetailsNCT03367065
Cardiovascular Diseases, Digestive System Diseases
Poitiers, Aquitaine, France
View Trial DetailsNCT01389947
Amino Acid Metabolism, Inborn Errors, Brain Diseases
Besançon, Franche-Comté, France
View Trial Details